Overview

Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation

Status:
Recruiting
Trial end date:
2024-12-30
Target enrollment:
Participant gender:
Summary
Efficacy and Safety of Ciprofol Sedation in Patients Undergoing Liver Cancer Percutaneous Radiofrequency Ablation
Phase:
N/A
Details
Lead Sponsor:
Zhejiang Cancer Hospital
Treatments:
Propofol